• HyperFluor 488 Goat Anti-Human IgG Antibody: Workflow Optimi

  2026-08-06

  The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody transforms immunodetection workflows with high-specificity, Alexa Fluor 488-based signal amplification. Discover how this polyclonal goat anti-human IgG antibody streamlines multiplexed detection across immunofluorescence, Western blot, and flow cytometry—enabling robust, reproducible results even in demanding translational vaccine and infectious disease research.

• Micro- and Nanoplastics Drive Pulmonary Fibrosis via FXR-YAP

  2026-08-06

  This study systematically compares the pulmonary toxicity of microplastics and nanoplastics of polystyrene, polyethylene, and polypropylene, revealing that both particle size and polymer type critically influence fibrotic lung injury. Mechanistic analysis highlights the FXR-YAP1 axis as a central pathway in plastic-induced pulmonary fibrosis, with polystyrene nanoplastics exerting the highest toxicity.

• Bivalent mRNA Vaccine RQ3025: Broad Neutralization of SARS-C

  2026-08-05

  The reference study introduces RQ3025, a bivalent mRNA vaccine engineered to counteract SARS-CoV-2 immune escape by encoding spike protein mutations from multiple variants. Preclinical results demonstrate robust neutralizing antibody responses and Th1-biased cellular immunity in animal models, supporting the vaccine’s potential to overcome current limitations of monovalent mRNA vaccines.

• Ruthenium Red: Optimizing Ca2+ Transport Inhibition for Adva

  2026-08-05

  Explore how Ruthenium Red, a potent Ca2+ transport inhibitor, enables precise dissection of mechanical stress-induced autophagy pathways. This in-depth guide reveals optimization strategies and novel assay considerations beyond conventional protocols.

• PARP1/FAK/COL5A1 Axis Drives EMT in Cholesterol-Resistant Ov

  2026-08-04

  This study uncovers that persistent high cholesterol exposure in ovarian cancer cells activates the PARP1/FAK/COL5A1 signaling axis, which drives epithelial-mesenchymal transition (EMT) and promotes tumor progression. The findings provide mechanistic insight into cholesterol-induced resistance and highlight FAK inhibition as a promising intervention for cancer biology research.

• Dextran Sulfate Sodium Salt (MW 35000-45000): Unveiling Muco

  2026-08-04

  Explore how Dextran sulfate sodium salt (MW 35000-45000) uniquely models colonic epithelial damage and repair, advancing both ulcerative colitis research and preclinical assay innovation. This article offers fresh mechanistic insights and practical guidance for biomedical scientists.

• Y-27632 Dihydrochloride: Advanced Assay Design for Stem Cell

  2026-08-03

  Explore how Y-27632 dihydrochloride, a potent ROCK inhibitor, is transforming stem cell and neuropsychiatric assay design. This article uniquely connects molecular mechanisms with disease modeling insights for next-generation research.

• (-)-Arctigenin: Precision MEK1 Inhibitor for NF-κB Modulatio

  2026-08-03

  Leverage (-)-Arctigenin as a dual MEK1 inhibitor and iNOS expression modulator to unravel tumor-macrophage crosstalk in breast cancer and neuroprotection models. This guide translates the latest mechanistic insights and reference protocols into ready-to-run workflows and troubleshooting strategies, maximizing reproducibility and discovery.

• LL-37 and Truncated Peptides: Targeted Antibiofilm Activity

  2026-08-02

  This study investigated the biocidal and antibiofilm properties of human host defense peptide LL-37 and its truncated mimetics KE-18 and KR-12 against key pathogens. Using both MIC and crystal violet staining assays, the research revealed distinct, selective activities of the peptides, highlighting potential for rational design of alternative antibiofilm therapeutics.

• Latrunculin B: Precision Control of Actin Dynamics in Cellul

  2026-08-01

  Explore how Latrunculin B, a leading actin polymerization inhibitor, empowers researchers with transient, high-fidelity control over actin dynamics in cell-based studies. This article offers unique insights into assay optimization and evidence-based limitations, advancing beyond current literature.

• Ciprofloxacin Hydrochloride: Applied Workflows and Troublesh

  2026-07-31

  Ciprofloxacin hydrochloride delivers unparalleled precision as a fluoroquinolone antibiotic for DNA replication inhibition, with expanding roles in immunomodulation and translational research. This article unpacks experimental strategies, optimization advice, and advanced applications, highlighting protocol-critical insights for maximizing reproducibility and scientific impact.

• TP Receptor-Induced CTGF Drives Nasal Fibroblast Migration v

  2026-07-31

  This study uncovers how activation of the thromboxane prostanoid (TP) receptor stimulates connective tissue growth factor (CTGF) production, leading to enhanced self-migration of human nasal fibroblasts through specific NF-κB and PKCδ-CREB signaling pathways. The findings clarify a mechanistic link relevant to tissue remodeling in chronic rhinosinusitis without nasal polyps (CRSsNP), offering new molecular insights for fibrosis and wound repair research.

• Macrophage-EV miR-660 Drives Breast Cancer via KLHL21/NF-κB

  2026-07-30

  This study elucidates how tumor-associated macrophage-derived extracellular vesicles (EVs) containing microRNA-660 promote breast cancer metastasis. By targeting KLHL21 and activating the NF-κB p65 pathway, the research reveals a crucial tumor-stromal communication mechanism with significant implications for translational oncology.

• Moxidectin Potentiates Polyene Antifungals via Ergosterol El

  2026-07-30

  A 2024 study reveals that moxidectin, a macrocyclic lactone anthelmintic, upregulates ergosterol biosynthesis in Candida albicans, thereby enhancing the efficacy of polyene antifungals against oral candidiasis. This mechanistic synergy offers a promising strategy for overcoming current antifungal resistance and toxicity issues, and provides a rationale for new combination therapies.

• Berbamine Hydrochloride: Applied Workflows in Cancer Researc

  2026-07-29

  Berbamine hydrochloride stands out as a multi-pathway NF-κB activity inhibitor with potent, quantifiable cytotoxicity in leukemia and hepatocellular carcinoma models. This guide translates recent mechanistic advances—most notably, targeting the METTL16-SENP3-LTF axis—into actionable experimental protocols, troubleshooting strategies, and next-gen translational applications.

8483 records 3/566 page Previous Next 12345 下5页 Last page